Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015;4(4):312-317.
doi: 10.1007/s13670-015-0141-x. Epub 2015 Jul 30.

Update on Disease-Modifying/Preventive Therapies in Alzheimer's Disease

Affiliations
Review

Update on Disease-Modifying/Preventive Therapies in Alzheimer's Disease

Jeffrey T Apter et al. Curr Geriatr Rep. 2015.

Abstract

Alzheimer's disease (AD) is increasingly becoming a major health problem throughout the US and Western Europe. As the remnants of the Baby Boom generation begin to reach their seniority at the turn of the twenty-first century, the disease has been unwillingly brought to the attention of the public eye. A disease that has traditionally been associated with an aging population has thus become a heated topic of discussion as modern research attempts to prevent and treat this major health burden and plague of the next decade.

Keywords: Alzheimer’s disease (AD); Amyloid Aβ; Amyloid plaques; Cognition; Early-onset Alzheimer’s disease; Late-onset Alzheimer’s disease; Medical illness; Mild AD; Mild cognitive impairment (MCI); Prodromal AD; Tau protein; ε4 allele.

PubMed Disclaimer

References

    1. Hardy JA, Higgins GA. Alzheimer’s disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184–5. doi: 10.1126/science.1566067. - DOI - PubMed
    1. Hampel H, Schneider LS, Giacobini E, Kivipelto M, Sindi S, Dubois B, et al. Advances in the therapy of Alzheimer’s disease: targeting amyloid beta and tau and perspectives for the future. Expert Rev Neurother. 2015;15(1):83–105. doi:10.1586/14737175.2015.995637. - PubMed
    1. Bettens K, Sleegers K, Van Broeckhoven C. Genetic insights in Alzheimer’s disease. Lancet Neurol. 2013;12(1):92–104. doi: 10.1016/S1474-4422(12)70259-4. - DOI - PubMed
    1. Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9(2):106–18. doi: 10.1038/nrneurol.2012.263. - DOI - PMC - PubMed
    1. Alzheimer’s & Parkinson’s Diseases Congress—AD/PD™ Nice Conference, 2015. N.p., 18 Mar. 2015. Web. 04 June 2015. http://www2.kenes.com/adpd/Pages/Home.aspx. Powerpoint Presentation Slides.

LinkOut - more resources